- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
EPHA2 Antibody / Receptor Tyrosine Kinase Antibody recognizes EPHA2, a member of the Eph family of receptor tyrosine kinases that mediates cell-cell communication through interactions with membrane-bound ephrin-A ligands. EPHA2 is widely expressed in epithelial tissues and regulates diverse processes including cell adhesion, migration, proliferation, differentiation, and tissue organization. Activation of EPHA2 signaling influences cellular positioning and contact-dependent communication, making this receptor an important regulator of development and tissue homeostasis. Originally identified as Epithelial Cell Kinase (ECK), EPHA2 has emerged as a key mediator of normal physiology and disease progression.
EPHA2 belongs to the largest family of receptor tyrosine kinases and consists of an extracellular ligand-binding domain, a transmembrane region, and an intracellular kinase domain. Binding of ephrin-A ligands initiates bidirectional signaling pathways that affect both receptor-expressing and ligand-expressing cells. Downstream signaling involves MAPK, PI3K/AKT, Src family kinases, and Rho GTPases, resulting in regulation of cytoskeletal dynamics, cell polarity, and migration. Through these mechanisms, EPHA2 contributes to embryonic development, angiogenesis, wound healing, and maintenance of epithelial architecture.
Aberrant EPHA2 expression and signaling have been implicated in numerous human diseases, particularly cancer. Elevated EPHA2 levels have been reported in breast cancer, lung cancer, prostate cancer, ovarian cancer, glioblastoma, melanoma, and colorectal cancer, where the receptor is associated with tumor progression, invasion, metastasis, and resistance to therapy. Depending on cellular context, EPHA2 can exhibit both tumor suppressive and oncogenic activities. Consequently, EPHA2 has become an important therapeutic target and biomarker in oncology. Beyond cancer, mutations in EPHA2 are linked to congenital cataracts and other developmental abnormalities, emphasizing its significance in normal tissue morphogenesis.
EPHA2 signaling also plays essential roles in vascular biology and inflammatory responses. Interactions with growth factor receptors, integrins, and cadherins allow EPHA2 to coordinate cellular responses to extracellular cues and maintain tissue integrity. Because Eph receptors are activated by cell-cell contact rather than soluble ligands, they represent a unique class of receptor tyrosine kinases that govern tissue patterning and cellular communication.
EPHA2 Antibody / Receptor Tyrosine Kinase Antibody is useful for investigations of developmental biology, cancer progression, cell migration, angiogenesis, and signal transduction. Detection of endogenous EPHA2 provides a valuable tool for studies of receptor tyrosine kinase signaling and diseases associated with altered cellular communication.
Visit our Signal Transduction Antibodies page to explore antibodies against receptor tyrosine kinases and other signaling proteins that regulate cell migration, tissue organization, and cancer progression.
Optimal dilution of the EPHA2 Antibody / Receptor Tyrosine Kinase Antibody should be determined by the researcher.
A recombinant human partial protein corresponding to amino acids M851-N970 was used as the immunogen for the Eph Receptor A2 / EPHA2 antibody.
After reconstitution, the Eph Receptor A2 / EPHA2 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
Eph Receptor A2 Antibody, EPHA2 Antibody, Ephrin Type-A Receptor 2 Antibody, Epithelial Cell Kinase Antibody, ECK Antibody, Tyrosine Protein Kinase Receptor ECK Antibody, Ephrin Receptor Antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.